CanSERV

HORIZON Research and Innovation Actions

01/09/2022 – 31/08/2025 (3 years)

Biobanks And Biomolecular Resources Research Infrastructure Consortium (BBMRI-ERIC)

VIEW PARTNERS >
View website

Arttic Innovation GMBH, Germany

Biobanks And Biomolecular Resources Research Infrastructure Consortium (BBMRI-ERIC), Austria

Centre International De Recherche Sur Le Cancer, France

EATRIS ERIC, Netherlands

ECRIN European Clinical Research Infrastructure Network, France

EURO-BIOIMAGING ERIC, Finland

European Infrastructure Of Open Screening Platforms For Chemical Biology European Research Infrastucture Consortium (EU-OPENSCREEN ERIC), Germany

European Marine Biological Resource Centre European Research Infrastructure Consortium, France

European Molecular Biology Laboratory, Germany

EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL, Belgium

Fundacio Privada Institut D’investigacio Oncologica De Vall-Hebron (VHIO), Spain

INFRAFRONTIER GMBH, Germany

INSTRUCT-ERIC, United Kingdom

The University of Manchester, United Kingdom

TTOPSTART BV, Netherlands

Universidade Do Minho, Portugal

Universita Degli Studi Di Torino, Italy

Wageningen University, Netherlands

Why it matters

CanSERV will offer key state-of-the-art RI services necessary to tackle all aspects and challenges of the development pipeline for oncology, as well as the translation to the clinic – from bench to bedside and back to bench- and the engagement with future users.

What ECPC does

ECPC will play a key role in this project, contributing to address social inequalities around Europe, promoting the access to cutting-edge services and tool-kits to better inform patients about public health measures and the accessibility to new advances in cancer research.

EU flag logo

This project has received funding from the European Union’s Horizon Europe Coordination and Support Actions programme under grant agreement No 101058620